From July 21, 2023 to August 17, 2023, the company has repurchased 665,000 shares, representing 0.72% for INR 598.5 million. With this, the company has completed the repurchase of 665,000 shares, representing 0.72% for INR 598.5 million under the buyback announced on July 21, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
462.1 INR | +0.92% | -7.83% | -5.51% |
05-06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 | |
05-03 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.51% | 509M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- News Aarti Drugs Limited
- Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.